These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27464)

  • 21. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
    Wellstein A; Belz GG; Palm D
    J Pharmacol Exp Ther; 1988 Jul; 246(1):328-37. PubMed ID: 2839668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of action and plasma levels of beta-adrenoceptor blocking drugs.
    Aellig WH
    Arch Int Pharmacodyn Ther; 1980; Suppl():32-7. PubMed ID: 6106456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Horký K; Urbánek J; Reiseauer R
    Sb Lek; 1975 Apr; 77(4):102-6. PubMed ID: 238277
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro.
    Wenkeová J; Kuhn E; Wenke M
    Eur J Pharmacol; 1976 May; 37(1):91-5. PubMed ID: 6293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY; Gorczynski RJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM; Singh BN; Ambler PK; Dorrington R
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
    Ishizaki T; Tawara K
    Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
    Johansson B
    Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
    Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P; Singer E; Kraupp O
    Arzneimittelforschung; 1977; 27(11):2063-6. PubMed ID: 23790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.